Millendo Therapeutics, Inc.
MLND
NASDAQ Capital Market1.06
USD
-0.06
- -
Total Valuation
Millendo Therapeutics, Inc. carries a market capitalization of 11.15M, placing it among publicly traded companies globally.
| Market Cap | 11.15M |
| Enterprise Value | N/A |
Stock Price Statistics
Millendo Therapeutics, Inc.'s stock has declined approximately -65.2459% over the past 52 weeks. The 50-day moving average sits at 18.86, while the 200-day moving average is 25.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -65.2459% |
| 50-Day Moving Average | 18.86 |
| 200-Day Moving Average | 25.14 |
| Average Volume (20 Days) | N/A |
Stock Splits
Millendo Therapeutics, Inc.'s most recent stock split took place on June 28, 2021 with a 15:1 split ratio.
| Last Split Date | 6/28/2021 |
| Split Ratio | 15:1 |